These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Genetic, molecular, and immunologic aspects of Vibrio cholerae infection]. Fica AE; Cabello FC Rev Med Chil; 1993 Mar; 121(3):312-20. PubMed ID: 8248646 [TBL] [Abstract][Full Text] [Related]
5. Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate. Levine MM; Black RE; Clements ML; Young CR; Lanata C; Sears S; Honda T; Finkelstein R Dev Biol Stand; 1983; 53():59-65. PubMed ID: 6873477 [TBL] [Abstract][Full Text] [Related]
6. [The centenary of the discovery of the vibrio El Tor (1905) or dubious beginnings of the seventh pandemic of cholera]. Chastel C Hist Sci Med; 2007; 41(1):71-82. PubMed ID: 17992832 [TBL] [Abstract][Full Text] [Related]
7. The opportunities & challenges in delivering oral cholera vaccines. Deen J; Sack DA Indian J Med Res; 2016 Aug; 144(2):149-150. PubMed ID: 27934792 [No Abstract] [Full Text] [Related]
8. Comparative behaviour of classical and El Tor biotypes of Vibrio cholerae 01 isolated in Bangladesh during 1982. Huq MI; Sanyal SC; Samadi AR; Monsur KA J Diarrhoeal Dis Res; 1983 Mar; 1(1):5-9. PubMed ID: 6384354 [TBL] [Abstract][Full Text] [Related]
9. Changing pattern of Vibrio cholerae serotype EL TOR and 0139 in Yavatmal (Maharashtra, India) during 1992 to 1994. Ingole KV; Jalgaonkar SV; Fule C; Fule RP Indian J Pathol Microbiol; 1997 Jul; 40(3):369-71. PubMed ID: 9354010 [TBL] [Abstract][Full Text] [Related]
10. [The new ("El Tor") cholera pandemic. Epidemiology, clinical aspects, possibilities of immunoprophylaxis]. Raettig H Munch Med Wochenschr; 1965 Oct; 107(44):2153-8. PubMed ID: 5899032 [No Abstract] [Full Text] [Related]
11. A review of the current status of enteric vaccines. Levine MM; Noriega F P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876 [TBL] [Abstract][Full Text] [Related]
16. [Lessons of cholera pandemic VII]. Pokrovskiĭ VI; Maramovich AS; Maleev VV Vestn Akad Med Nauk SSSR; 1989; (9):60-7. PubMed ID: 2588780 [TBL] [Abstract][Full Text] [Related]
17. Genetic manipulation of Vibrio cholerae for vaccine development: construction of live attenuated El Tor candidate vaccine strains. Benítez JA; Silva AJ; Rodríguez BL; Fando R; Campos J; Robert A; García H; García L; Pérez JL; Oliva R; Torres CA; Ledón T Arch Med Res; 1996; 27(3):275-83. PubMed ID: 8854382 [TBL] [Abstract][Full Text] [Related]
18. Process development for a Cuban cholera vaccine based on the attenuated strain Vibrio cholerae 638. Talavera A; Año G; García H; Moreira T; Delgado H; Riverón L; Gil S; Miranda A; Cedré B; Valmaseda T; Pino Y; Pérez JL; Infante JF; García L; Sierra G Vaccine; 2006 May; 24(18):3746-9. PubMed ID: 16085342 [TBL] [Abstract][Full Text] [Related]
19. Intraduodenal inoculation of adult rabbits for evaluating the immunogenicity of genetically attenuated Vibrio cholerae strains. García Imia L; Oliva Hernández R; Cedré Marrero B; Valmaseda Pérez T; García Sánchez H; Talavera Coronel A; Pérez Quiñoy JL; Sierra González G Lab Anim Sci; 1998 Oct; 48(5):538-41. PubMed ID: 10090073 [No Abstract] [Full Text] [Related]
20. [Resistance to antibiotics of Vibrio cholerae and its possible prognostic significance]. Ved'mina EA; Givental' NI; Sobolev VR; Ogneva NS; Voronin IuS Antibiotiki; 1984 Apr; 29(4):260-3. PubMed ID: 6742803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]